AKT1 and plasma cell myeloma: It has been demonstrated that the PI3K signaling pathway is an active player in the MM progression, and its inhibition results into the prevention of the proliferation and growth of myeloma cell lines.27,50 Activation (phosphorylation) of Akt mainly through the PI3K signaling in myeloma cells is accompanied by the poor prognosis and the reduced patient survival.